ষ্টেম চেল ট্ৰান্সপ্লাণ্টৰ পিছৰ যতন
Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients
ক’ত যাব
ভাৰতৰ 2 খন হাস্পতালত এই trial-ৰ বাবে ৰোগী লৈ আছে।
ৰেজিষ্ট্ৰীৰ সাৰাংশ (কাৰিকৰী)
What is acute Graft versus host disease (aGvHD)? GvHD is a complication that can occur after an allogeneic stem cell transplant resulting in damage to some organs. The death rate of GvHD patients is 15-40%. In GvHD, the donated peripheral blood stem cells or bone marrow view the recipient's body as foreign, and the donated cells/bone marrow harm the body. aGvHD usually develops in skin, liver or gastrointestinal tract, and symptoms might appear within few weeks after transplant. Symptoms of acute GvHD are observed as skin rash or reddened areas on the skin, yellow discoloration of the skin and…
স্পন্সৰ: Tata Memorial Centre
ClinicalTrials.gov-ত NCT07724873
ৰেজিস্ট্ৰীত শেষবাৰ আপডেট কৰা হৈছে 24 Jul 2026 · আমি পঢ়িছোঁ 20 Oct 2026